HEPA
Hepion Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.09
+33.33%Aug 27, 2026, 00:00 UTC
Hepion Pharmaceuticals entered into securities purchase agreements to sell 8,000,000 shares of common stock and warrants for 8,000,000 shares at $0.05 per share, raising gross proceeds of $400,000.
Aug 20, 2026, 00:00 UTC
James Liddy was appointed as a director of Hepion Pharmaceuticals, Inc., effective August 19, 2026.
Aug 4, 2026, 00:00 UTC
Hepion Pharmaceuticals, Inc. signed a private placement agreement on August 3, 2026, to issue 61,100,000 shares of common stock and warrants for an additional 61,100,000 shares, raising gross proceeds of $3,055,000.